-
Product Name
Anti-PRTFDC1 antibody
- Documents
-
Description
Mouse monoclonal to PRTFDC1
-
Tested applications
WB
-
Species reactivity
Human PRTFDC1
-
Alternative names
Gm13377 antibody; HHGP antibody; OTTMUSG00000011667 antibody; phosphoribosyl transferase domain containing 1 antibody; phosphoribosyltransferase domain containing 1 pseudogene antibody; phosphoribosyltransferase domain-containing protein 1 antibody; Prtfdc1 antibody; PRTFDC1 antibody; RP11-129O7.1 antibody
- Immunogen
-
Preparation
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human PRTFDC1 (rh PRTFDC1; Q9NRG1-1; Met1-Val225). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
-
Clonality
Monoclonal
-
Formulation
0.2 μm filtered solution in PBS with 5% treha
-
Storage instructions
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles. -
Applications
WB: 20-30 μg/ml
-
Validations
PRTFDC1 Antibody, Mouse MAb, Western blot
-
Background
PRTFDC1 is a member of the purine/pyrimidine phosphoribosyltransferase family. It can bind GMP, IMP and alpha-D-5-phosphoribosyl 1-pyrophosphate (PRPP). The epigenetic silencing of PRTFDC1 by hypermethylation of the CpG island leads to a loss of PRTFDC1 function, which might be involved in squamous cell oral carcinogenesis. PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouse and has important implications for unraveling the molecular etiology of lesch-Nyhan disease(LND). LND is a severe X-linked neurological disorder caused by a deficiency of hypoxanthine phosphoribosyltransferase. PRTFDC1 has a low, barely measurable phosphoribosyltransferase activity (in vitro).
-
References
- Welin M. et al., 2010, FEBS J. 277 (23): 4920-30.
- Keebaugh AC. et al., 2011, PLoS One. 6 (7): e22381.
- Suzuki E. et al., 2007, Oncogene. 26 (57): 7921-32.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"